CTRI/2024/01/061187
Not yet recruiting
未知
A Prospective Observational Cohort Studyto Analyse the Etiology of Revision LumbarSpine Surgery at a Tertiary CareSpine Institute. - NI
Stavya Spine Hospital and Research Institute0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system
- Sponsor
- Stavya Spine Hospital and Research Institute
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •cases previously operated for stenosis, spondylolisthesis, disc prolapse, infections.
- •cases previously operated by endoscopic spine surgery, MIS spine surgery, open spine
- •cases giving consent for surgery.
- •Age group 18 and above
Exclusion Criteria
- •patients who are not willing to be a part of study.
- •Age below 18\.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Investigating the Causes of Revision Lumbar Spine Surgery: A 6-Month Follow-up Prospective Observational Study at a Tertiary Care Spine InstituteHealth Condition 1: M430- SpondylolysisCTRI/2024/01/061208Stavya Spine Hospital and Research Institute
Not yet recruiting
Not Applicable
This is a type of cancer found in elderly patientsCTRI/2022/09/045751Investigator initiated trial
Recruiting
Not Applicable
A study to assess the usefulness of various tests done for the monitoring of long term complications in survivors of leukemia and lymphoma.CTRI/2019/06/019880Tata Memorial Centre Research Administrative council
Recruiting
Not Applicable
A prospective observational cohort study to identify novel therapeutic efficacy indicators for patients with pulmonary hypertensioJPRN-UMIN000039741Ministry of Health, Labor and Welfare100
Not yet recruiting
Not Applicable
Rate of multidrug resistance to antimicrobial drugs in paediatric neurointensive care patientsHealth Condition 1: Z163- Resistance to other antimicrobialdrugsCTRI/2019/10/021721All India institute of medical sciences